Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.
暂无分享,去创建一个
J. Rabinowitz | G. Rengo | Joseph E Rabinowitz | C. Zincarelli | Giuseppe Rengo | Carmela Zincarelli | Stephen Soltys | S. Soltys
[1] R. Samulski,et al. Infectious Entry Pathway of Adeno-Associated Virus and Adeno-Associated Virus Vectors , 2000, Journal of Virology.
[2] Theresa A. Storm,et al. Liver Transduction with Recombinant Adeno-Associated Virus Is Primarily Restricted by Capsid Serotype Not Vector Genotype , 2006, Journal of Virology.
[3] M. R. Delgado Alvira,et al. Adeno-associated viruses undergo substantial evolution in primates during natural infections , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Peterson,et al. Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] James M. Allen,et al. Adeno-Associated Virus Type 6 (AAV6) Vectors Mediate Efficient Transduction of Airway Epithelial Cells in Mouse Lungs Compared to That of AAV2 Vectors , 2001, Journal of Virology.
[6] J. Wolfe,et al. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] T. Magnuson,et al. Targeted mutation of Ncam to produce a secreted molecule results in a dominant embryonic lethality. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Linden,et al. The cryptic life style of adenoassociated virus , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[9] C. Contag,et al. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] R. Samulski,et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[11] P. Reier,et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] Linda Yang,et al. Cloning and Characterization of Adeno-Associated Virus Type 5 , 1999, Journal of Virology.
[13] Theresa A. Storm,et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[14] Bing Wang,et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart , 2005, Nature Biotechnology.
[15] M. Hallek,et al. Targeted Gene Delivery to Vascular Tissue In Vivo by Tropism-Modified Adeno-Associated Virus Vectors , 2004, Circulation.
[16] R. Klein,et al. AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[17] R. Hajjar,et al. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo , 2007, Gene Therapy.
[18] M. Odenthal,et al. Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] Theresa A. Storm,et al. Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectors , 2004, Journal of Virology.
[20] R. Samulski,et al. Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity , 2002, Journal of Virology.
[21] Lili Wang,et al. Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. , 2004, Blood.
[22] D. Grimm,et al. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. , 2006, Cardiovascular research.
[23] R. Kotin,et al. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles , 1997, Journal of virology.
[24] Theresa A. Storm,et al. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. , 2003, Blood.
[25] Theresa A. Storm,et al. Large-Scale Molecular Characterization of Adeno-Associated Virus Vector Integration in Mouse Liver , 2005, Journal of Virology.
[26] T. Zhu,et al. Efficient and long-term intracardiac gene transfer in δ-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors , 2003, Gene Therapy.
[27] J. Pessin,et al. Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection , 1999, Journal of Virology.
[28] Charles R. Gerfen,et al. Current Protocols In Neuroscience , 1999 .
[29] Vasilis Ntziachristos,et al. Shedding light onto live molecular targets , 2003, Nature Medicine.
[30] Zeger Debyser,et al. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. , 2007, Human gene therapy.
[31] S. Harper,et al. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[32] Lili Wang,et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] T. Conlon,et al. Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo , 2006, Circulation research.
[34] James M. Allen,et al. Repeat Transduction in the Mouse Lung by Using Adeno-Associated Virus Vectors with Different Serotypes , 2000, Journal of Virology.
[35] M. R. Delgado Alvira,et al. Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues , 2004, Journal of Virology.
[36] D. Russell,et al. Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2 , 1998, Journal of Virology.
[37] S S Gambhir,et al. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[38] James M. Wilson,et al. High-Level Transgene Expression in Nonhuman Primate Liver with Novel Adeno-Associated Virus Serotypes Containing Self-Complementary Genomes , 2006, Journal of Virology.
[39] J. Gray,et al. Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. , 2007, Blood.
[40] James M. Allen,et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors , 2004, Nature Medicine.
[41] O. Danos,et al. Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome Degradation , 2001, Journal of Virology.